Nicholas Sarlis: Dr Luis Raez succinctly describes recently reported results from key clinical trials in NSCLC patients

Nicholas Sarlis, Chief Medical Officer at CLEARA Biotech BV, shared a post on LinkedIn:

“Dr. Luis E Raez, a renowned lung cancer expert and eminent ex-collaborator, succinctly describes recently reported results from key clinical trials in NSCLC patients, namely PAPILLON, CHECKMATE 77T, and KEYNOTE-671. The VuMedi video below also provides the meaning of these recent NSCLC updates along with their ‘positioning’ across a complex and rapidly evolving therapeutic landscape.”

Proceed to the video.
Source: Nicholas Sarlis/LinkedIn